Expression of the Breast Cancer Metastasis Suppressor 1 (BRMS1) maintains in vitro chemosensitivity of breast cancer cells

Cancer Letters

Volumn 281, Issue 1, 2009, Pages 100-107

  Vaidya, Kedar S ^a   Sanchez, Jesus J ^a   Kim, Eun Lim ^a   Welch, Danny R ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

3D culture; Breast cancer; Breast Cancer Metastasis Suppressor 1 (BRMS1); Chemoresistance; Metastasis

Indexed keywords

BETA ACTIN; BREAST CANCER METASTASIS SUPPRESSOR 1; DOXORUBICIN; FLUOROURACIL; PACLITAXEL; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B BETA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; BREAST CANCER; CANCER RESISTANCE; CELL PROLIFERATION; CHEMOSENSITIVITY; CLONOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; PACLITAXEL; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECOMBINANT FUSION PROTEINS; TUMOR STEM CELL ASSAY; VINCRISTINE;

EID: 67349265766     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.02.035     Document Type: Article

References (46)

1. Stafford L.J., Vaidya K.S., and Welch D.R. Metastasis suppressors genes in cancer. Int. J. Biochem. Cell Biol. 40 (2008) 874-891
2. Vaidya K.S., and Welch D.R. Metastasis suppressors and their roles in breast carcinoma. J. Mamm. Gland Biol. Neopl. 12 (2007) 175-190
3. Eccles S.A., and Welch D.R. Metastasis: recent discoveries and novel treatment strategies. Lancet 369 (2007) 1742-1757
4. Seraj M.J., Samant R.S., Verderame M.F., and Welch D.R. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res. 60 (2000) 2764-2769
5. Shevde L.A., Samant R.S., Goldberg S.F., Sikaneta T., Alessandrini A., Donahue H.J., Mauger D.T., and Welch D.R. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Exp. Cell Res. 273 (2002) 229-239
6. Zhang S., Lin Q.D., and Di W. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1. Int. J. Gynecol. Cancer 16 (2006) 522-531
7. Hicks D.G., Yoder B.J., Short S., Tarr S., Prescott N., Crowe J.P., Dawson A.E., Budd G.T., Sizemore S., Cicek M., Choueiri T., Tubbs R.R., Gaile D., Nowak N., Accavitti-Loper M.A., Frost A.R., Welch D.R., and Casey G. Loss of BRMS1 protein expression predicts reduced disease-free survival in hormone receptor negative and HER2 positive subsets of breast cancer. Clin. Cancer Res. 12 (2006) 6702-6708
8. Stark A.M., Tongers K., Maass N., Mehdorn H.M., and Held-Feindt J. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. J. Cancer Res. Clin. Oncol. 131 (2004) 191-198
9. Zhang Z., Yamashita H., Toyama T., Yamamoto Y., Kawasoe T., and Iwase H. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer. Clin. Cancer Res. 12 (2006) 6410-6414
10. Metge B.J., Frost A.R., King J.A., Dyess D.L., Welch D.R., Samant R.S., and Shevde L.A. Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer. Clin. Exp. Metastasis 25 (2008) 753-763
11. Palmieri D., Halverson D.O., Ouatas T., Horak C.E., Salerno M., Johnson J., Figg W.D., Hollingshead M., Hursting S., Berrigan D., Steinberg S.M., Merino M.J., and Steeg P.S. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. J. Natl. Cancer Inst. 97 (2005) 632-642
12. Hedley B.D., Vaidya K.S., Phadke P., MacKenzie L., Dales D.W., Postenka C.O., MacDonald I.C., and Chambers A.F. BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation. Clin. Exp. Metastasis 25 (2008) 727-740
13. Phadke P.A., Vaidya K.S., Nash K.T., Hurst D.R., and Welch D.R. BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. Am. J. Pathol. 172 (2008) 809-817
14. Meehan W.J., Samant R.S., Hopper J.E., Carrozza M.J., Shevde L.A., Workman J.L., Eckert K.A., Verderame M.F., and Welch D.R. Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J. Biol. Chem. 279 (2004) 1562-1569
15. Hurst D.R., Mehta A., Moore B.P., Phadke P.A., Meehan W.J., Accavitti M.A., Shevde L.A., Hopper J.E., Xie Y., Welch D.R., and Samant R.S. Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone. Biochem. Biophys. Res. Commun. 348 (2006) 1429-1435
16. Yoshida M., Furumai R., Nishiyama M., Komatsu Y., Nishino N., and Horinouchi S. Histone deacetylase as a new target for cancer chemotherapy. Cancer Chemother. Pharmacol. 48 (2001) S20-S26
17. Vaidya K.S., Harihar S., Stafford L.J., Hurst D.R., Hicks D.G., Casey G., DeWald D.B., and Welch D.R. Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling. J. Biol. Chem. 283 (2008) 28354-28360
18. Hedley B.D., Welch D.R., Allan A.L., Al-Katib W., Dales D.W., Postenka C.O., Casey G., MacDonald I.C., and Chambers A.F. Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1. Int. J. Cancer 123 (2008) 526-534
19. Samant R.S., Clark D.W., Fillmore R.A., Cicek M., Metge B.J., Chandramouli K.H., Chambers A.F., Casey G., Welch D.R., and Shevde L.A. Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation. Mol. Cancer 6 (2007) 6
20. DeWald D.B., Torabinejad J., Samant R.S., Johnston D., Erin N., Shope J.C., Xie Y., and Welch D.R. Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells. Cancer Res. 65 (2005) 713-717
21. Cicek M., Fukuyama R., Welch D.R., Sizemore N., and Casey G. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-κB activity. Cancer Res. 65 (2005) 3586-3595
22. Saunders M.M., Seraj M.J., Li Z.Y., Zhou Z.Y., Winter C.R., Welch D.R., and Donahue H.J. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res. 61 (2001) 1765-1767
23. Cheng J.Q., Lindsley C.W., Cheng G.Z., Yang H., and Nicosia S.V. The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene 24 (2005) 7482-7492
24. Pham C.G., Bubici C., Zazzeroni F., Knabb J.R., Papa S., Kuntzen C., and Franzoso G. Upregulation of Twist-1 by NF-kappaB blocks cytotoxicity induced by chemotherapeutic drugs. Mol. Cell. Biol. 27 (2007) 3920-3935
25. Sebens S., Arlt A., and Schafer H. NF-kappaB as a molecular target in the therapy of pancreatic carcinoma. Recent Results Cancer Res. 177 (2008) 151-164
26. Rivera J., Megias D., and Bravo J. Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1. J. Proteome Res. 6 (2007) 4006-4018
27. Cailleau R., Olive M., and Cruciger Q.V.J. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14 (1978) 911-915
28. Hurst D.R., Xie Y., Vaidya K.S., Mehta A., Moore B.P., Accavitti-Loper M.A., Samant R.S., Saxena R., Silveira A.C., and Welch D.R. Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells. J. Biol. Chem. 283 (2008) 7438-7444
29. Welch D.R., and Nicolson G.L. Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to Adriamycin 5-fluoro-2′-deoxyuridine and methotrexate treatment in vitro. Clin. Exp. Metastasis 1 (1983) 317-325
30. Weaver V.M., Fischer A.H., Peterson O.W., and Bissell M.J. The importance of the microenvironment in breast cancer progression: Recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay. Biochem. Cell Biol. 74 (1996) 833-851
31. Debnath J., and Brugge J.S. Modelling glandular epithelial cancers in three-dimensional cultures. Nature Rev. Cancer 5 (2005) 675-688
32. Smalley K.S., Lioni M., and Herlyn M. Life isn't flat: taking cancer biology to the next dimension. In Vitro Cell Dev. Biol. Anim. 42 (2006) 242-247
33. Nakamura T., Kato Y., Fuji H., Horiuchi T., Chiba Y., and Tanaka K. E-cadherin-dependent intercellular adhesion enhances chemoresistance. Int. J. Mol. Med. 12 (2003) 693-700
34. Jones S.E. Metastatic breast cancer: the treatment challenge. Clin. Breast Cancer 8 (2008) 224-233
35. Li X., Guo X., Li F., Li X., Guan C., Yang H., Pan Z., Li C., and Ren Z. Expression and clinical significance of breast cancer metastasis suppressor 1 mRNA in supraglottic laryngeal carcinoma. Lin. Chung Er. Bi Yan. Hou Tou. Jing. Wai Ke. Za Zhi. 22 (2008) 241-244
36. Thompson M.G., Chahwala S.B., and Hickman J.A. Inhibition of human erythrocyte inositol lipid metabolism by adriamycin. Cancer Res. 47 (1987) 2799-2803
37. Huang Y., Fang Y., Dziadyk J.M., Norris J.S., and Fan W. The possible correlation between activation of NF-kappaB/IkappaB pathway and the susceptibility of tumor cells to paclitaxel-induced apoptosis. Oncol. Res. 13 (2002) 113-122
38. Huang Y., Fang Y., Wu J., Dziadyk J.M., Zhu X., Sui M., and Fan W. Regulation of Vinca alkaloid-induced apoptosis by NF-kappaB/IkappaB pathway in human tumor cells. Mol. Cancer Ther. 3 (2004) 271-277
39. Samant R.S., Seraj M.J., Saunders M.M., Sakamaki T., Shevde L.A., Harms J.F., Leonard T.O., Goldberg S.F., Budgeon L.R., Meehan W.J., Winter C.R., Christensen N.D., Verderame M.F., Donahue H.J., and Welch D.R. Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clin. Exp. Metastasis 18 (2001) 683-693
40. Samant R.S., Debies M.T., Hurst D.R., Moore B.P., Shevde L.A., and Welch D.R. Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1). Cancer Lett. 235 (2006) 260-265
41. Eidinoff M.L., Knoll J.E., and Klein D. Effect of 5-fluorouracil on the incorporation of precursors into nucleic acid pyrimidines. Arch. Biochem. Biophys. 71 (1957) 274-275
42. Champine P.J., Michaelson J., Weimer B., Welch D.R., and DeWald D.B. Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression. Clin. Exp. Metastasis 24 (2007) 551-565
43. Mabuchi S., Ohmichi M., Nishio Y., Hayasaka T., Kimura A., Ohta T., Kawagoe J., Takahashi K., Yada-Hashimoto N., Seino-Noda H., Sakata M., Motoyama T., Kurachi H., Testa J.R., Tasaka K., and Murata Y. Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Clin. Cancer Res. 10 (2004) 7645-7654
44. Liu Y., Smith P.W., and Jones D.R. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. Mol. Cell. Biol. 26 (2006) 8683-8696
45. Dhawan P., and Richmond A. A novel NF-κB-inducing kinase-MAPK signaling pathway up-regulates NF-κB activity in melanoma cells. J. Biol. Chem. 277 (2002) 7920-7928
46. Dhawan P., Singh A.B., Ellis D.L., and Richmond A. Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-κB and tumor progression. Cancer Res. 62 (2002) 7335-7342